The Big Thing to Know About Moderna's COVID Vaccine Results

Keith Speights, The Motley Fool
·3-min read

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) were the first drugmakers to announce interim efficacy results from a late-stage study of their coronavirus vaccine candidate. Moderna (NASDAQ: MRNA) had its turn last week. Corinne Cardina: Turning now, we have Keith Speights coming on.